Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Huang Chen

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Cell Death & Disease|April 22, 2022
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axisYu-Chan Chang, Chien-Hsiu Li, Ming-Hsien Chan, et al.
Gene|December 11, 2012
In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening resultWu-Lung R Yang, Yu-En Lee, Ming-Huang Chen, et al.
Molecular Cancer|August 9, 2017
Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosisYu-Chan Chang, Chia-Yi Su, Ming-Huang Chen, et al.
Lupus Science & Medicine|June 23, 2022
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic responseJan-Mou Lee, Ming-Huang Chen, Kai-Yuan Chou, et al.
Annals of the Rheumatic Diseases|June 30, 2021
Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic diseaseMing-Han Chen, I-Cheng Lee, Ming-Huang Chen, et al.
Frontiers in Immunology|November 7, 2022
Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinomaYi-Ru Pan, Chiao-En Wu, Wen-Kuan Huang, et al.
Hepatology International|November 23, 2024
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapyKuan-Chang Lai, Yen-Hao Chen, Yi-Ping Hung, et al.
Clinical Rheumatology|August 3, 2011
Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndromeMing-Han Chen, Liang-Tsai Hsiao, Ming-Huang Chen, et al.
Anticancer Research|July 26, 2024
Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal CancersWen-Chi Wu, Chien-Fu Hsu, Ming-Huang Chen, et al.
Clinical and Experimental Rheumatology|September 9, 2016
Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort studyMing-Han Chen, Chun-Ku Chen, Hsiao-Ping Chou, et al.
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Cell Death & Disease|April 22, 2022
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axisYu-Chan Chang, Chien-Hsiu Li, Ming-Hsien Chan, et al.
Gene|December 11, 2012
In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening resultWu-Lung R Yang, Yu-En Lee, Ming-Huang Chen, et al.
Molecular Cancer|August 9, 2017
Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosisYu-Chan Chang, Chia-Yi Su, Ming-Huang Chen, et al.
Lupus Science & Medicine|June 23, 2022
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic responseJan-Mou Lee, Ming-Huang Chen, Kai-Yuan Chou, et al.
Annals of the Rheumatic Diseases|June 30, 2021
Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic diseaseMing-Han Chen, I-Cheng Lee, Ming-Huang Chen, et al.
Frontiers in Immunology|November 7, 2022
Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinomaYi-Ru Pan, Chiao-En Wu, Wen-Kuan Huang, et al.
Hepatology International|November 23, 2024
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapyKuan-Chang Lai, Yen-Hao Chen, Yi-Ping Hung, et al.
Clinical Rheumatology|August 3, 2011
Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndromeMing-Han Chen, Liang-Tsai Hsiao, Ming-Huang Chen, et al.
Anticancer Research|July 26, 2024
Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal CancersWen-Chi Wu, Chien-Fu Hsu, Ming-Huang Chen, et al.
Clinical and Experimental Rheumatology|September 9, 2016
Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort studyMing-Han Chen, Chun-Ku Chen, Hsiao-Ping Chou, et al.
Pageof 19